Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Thomas Morrow"'
Autor:
Jana C. Schierjott, Garrett Ito, Mark D. Behn, Xiaochuan Tian, Thomas Morrow, Boris J. P. Kaus, Javier Escartín
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Oceanic detachment faults represent an end-member form of seafloor creation, associated with relatively weak magmatism at slow-spreading mid-ocean ridges. We use 3-D numerical models to investigate the underlying mechanisms for why detachmen
Externí odkaz:
https://doaj.org/article/23c60ca0228f4698ad8a1926f8558698
This paper describes the development of a Microsoft (MS) Excel workbook calculator that estimates the dose rate of a neutron activated sample by calculating the activity and associated dose rate contributions of key isotopes. The goal of the calculat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be227bd19f96407f691f1206f99f152a
Transform faults and non-transform offsets define the bounds of mid-ocean ridge spreading segments, but tectonic and magmatic controls on the length of segments and the morphology of intervening offsets are poorly understood. A general observation at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efb2291c011f1260c0a26931a9c83247
https://doi.org/10.5194/egusphere-egu22-8822
https://doi.org/10.5194/egusphere-egu22-8822
Publikováno v:
2012 ASEE Annual Conference & Exposition Proceedings.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98b18ae97f2225e703d1e719374623e5
https://doi.org/10.18260/1-2--20790
https://doi.org/10.18260/1-2--20790
Autor:
Thomas, Morrow
Publikováno v:
The American journal of managed care. 25
Idiopathic pulmonary fibrosis (IPF) is a chronic pulmonary disease that is complicated by diagnostic challenges, multiple comorbidities, and a poor prognosis. Although considered a relatively rare disease, healthcare costs are substantial and disprop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::69a87d7c40b5daf5b7c0b8535327b07b
https://pubmed.ncbi.nlm.nih.gov/31419090
https://pubmed.ncbi.nlm.nih.gov/31419090
Autor:
Thomas, Morrow
Publikováno v:
Managed care (Langhorne, Pa.). 27(6)
Trogarzo (ibalizumab-uiyk) is a CD4-directed post-attachment HIV-1 inhibitor, indicated for use with other antiretroviral inhibitors in adults with multidrug resistant HIV-1 infection who aren't responding to their antiretroviral regimen. It is consi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f6401c9c4fa3cd2b27962ca07d8972c
https://pubmed.ncbi.nlm.nih.gov/29989910
https://pubmed.ncbi.nlm.nih.gov/29989910
Autor:
Thomas, Morrow
Publikováno v:
Managed care (Langhorne, Pa.). 27(4)
Diabetes is the scourge of our times, but we have been chasing the wrong culprits. A simple, $40 test of insulin resistance could put us on the right track.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::edc0894f0135aabca4e2b10108c68b1f
https://pubmed.ncbi.nlm.nih.gov/29701589
https://pubmed.ncbi.nlm.nih.gov/29701589
Autor:
Thomas, Morrow
Publikováno v:
Managed care (Langhorne, Pa.). 27(2)
Hemlibra demonstrates how far antibody science has progressed. Genentech's drug, approved late last year, connects two clotting factors to prevent the devastating bleeds in hemophilia patients with inhibitors. The high price may be offset by avoided
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d363e32cdc9fd187b07e09f5eb6b0dfa
https://pubmed.ncbi.nlm.nih.gov/29451467
https://pubmed.ncbi.nlm.nih.gov/29451467
Autor:
Thomas, Morrow
Publikováno v:
Managed care (Langhorne, Pa.). 27(1)
Ingrezza and Austedo were approved last year. ICER calculations raise questions about their price.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b79ca52888d938d098dd6761af4ac0cc
https://pubmed.ncbi.nlm.nih.gov/29369770
https://pubmed.ncbi.nlm.nih.gov/29369770
Autor:
Thomas, Morrow
Publikováno v:
Managed care (Langhorne, Pa.). 26(11)
A partnership that includes two not-for-profit organizations beats out a company formerly led by "pharma bro" Martin Shkreli for the FDA's OK of benznidazole.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4a9c138db4b39910521e72e45abcb3dc
https://pubmed.ncbi.nlm.nih.gov/29185981
https://pubmed.ncbi.nlm.nih.gov/29185981